Appointment | December 01, 2021
Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
Subscribe To Our Newsletter & Stay Updated
